The tricks for fighting against cancer using CAR NK cells: A review
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The tricks for fighting against cancer using CAR NK cells: A review
Authors
Keywords
Cancer, NK cells, Cancer immunotherapy, CAR-NK
Journal
MOLECULAR AND CELLULAR PROBES
Volume 63, Issue -, Pages 101817
Publisher
Elsevier BV
Online
2022-04-15
DOI
10.1016/j.mcp.2022.101817
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potential Role of Hsp70 and Activated NK Cells for Prediction of Prognosis in Glioblastoma Patients
- (2021) Dominik Lobinger et al. Frontiers in Molecular Biosciences
- CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies
- (2021) Faroogh Marofi et al. Stem Cell Research & Therapy
- CAR-NK Cell: A New Paradigm in Tumor Immunotherapy
- (2021) Faroogh Marofi et al. Frontiers in Oncology
- Erb‑B2 Receptor Tyrosine Kinase 2 is negatively regulated by the p53‑responsive microRNA‑3184‑5p in cervical cancer cells
- (2020) Hongli Liu et al. ONCOLOGY REPORTS
- Outcomes of patients with large B‐cell lymphomas and progressive disease following CD19‐specific CAR T‐cell therapy
- (2019) Victor A. Chow et al. AMERICAN JOURNAL OF HEMATOLOGY
- Genetic Reprogramming For NK cell Cancer Immunotherapy with CRISPR /Cas9
- (2019) Lukman O. Afolabi et al. IMMUNOLOGY
- CAR-NK for tumor immunotherapy: Clinical transformation and future prospects
- (2019) Wenxiu Wang et al. CANCER LETTERS
- Natural killer cells and cancer therapy, what we know and where we are going
- (2019) Faezeh Ghaemdoust et al. Immunotherapy
- 4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses
- (2018) Ashley V. Menk et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
- (2018) Qing Zhang et al. NATURE IMMUNOLOGY
- Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
- (2018) Rohtesh S. Mehta et al. Frontiers in Immunology
- Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
- (2018) Pascale André et al. CELL
- Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study
- (2018) Ahmed Hosny et al. PLOS MEDICINE
- Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma
- (2018) Xingliang Guo et al. Frontiers in Pharmacology
- Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy
- (2017) Janet Ayello et al. EXPERIMENTAL HEMATOLOGY
- Tricking the balance: NK cells in anti-cancer immunity
- (2017) Jens Pahl et al. IMMUNOBIOLOGY
- Natural Killer Cells: Angels and Devils for Immunotherapy
- (2017) Beatriz Martín-Antonio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization
- (2017) Silvia Pesce et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
- (2017) Paul A. Beavis et al. JOURNAL OF CLINICAL INVESTIGATION
- Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity
- (2017) E Liu et al. LEUKEMIA
- Masked Chimeric Antigen Receptor for Tumor-Specific Activation
- (2017) Xiaolu Han et al. MOLECULAR THERAPY
- CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
- (2017) Levi J. Rupp et al. Scientific Reports
- An oxygen sensitive self-decision making engineered CAR T-cell
- (2017) Alexandre Juillerat et al. Scientific Reports
- Natural Killer Cell-Based Cancer Immunotherapies: From Immune Evasion to Promising Targeted Cellular Therapies
- (2017) Erhard Hofer et al. Frontiers in Immunology
- Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells As an “Off-the-Shelf Immunotherapy” for Improvement in Cancer Treatment
- (2017) Olaf Oberschmidt et al. Frontiers in Immunology
- Umbilical Cord Blood Natural Killer Cells, Their Characteristics, and Potential Clinical Applications
- (2017) Anushruti Sarvaria et al. Frontiers in Immunology
- Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
- (2017) Congcong Zhang et al. Frontiers in Immunology
- Natural Killer Cell Memory: Progress and Implications
- (2017) Hui Peng et al. Frontiers in Immunology
- Romidepsin alone or in combination with anti-CD20 chimeric antigen receptor expanded natural killer cells targeting Burkitt lymphoma in vitro and in immunodeficient mice
- (2017) Yaya Chu et al. OncoImmunology
- Signal transducer and activator of transcription proteins: regulators of myeloid-derived suppressor cell-mediated immunosuppression in cancer
- (2016) Hyun-Jeong Ko et al. ARCHIVES OF PHARMACAL RESEARCH
- Diverse macrophages polarization in tumor microenvironment
- (2016) Inmoo Rhee ARCHIVES OF PHARMACAL RESEARCH
- Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits
- (2016) Kole T. Roybal et al. CELL
- Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors
- (2016) Leonardo Morsut et al. CELL
- NK cell education via nonclassical MHC and non-MHC ligands
- (2016) Yuke He et al. Cellular & Molecular Immunology
- Chimeric antigen receptors: driving immunology towards synthetic biology
- (2016) Michel Sadelain CURRENT OPINION IN IMMUNOLOGY
- Cryopreservation has no effect on function of natural killer cells differentiated in vitro from umbilical cord blood CD34 + cells
- (2016) Anna Domogala et al. CYTOTHERAPY
- Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
- (2016) Omkar U. Kawalekar et al. IMMUNITY
- Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma
- (2016) Avery D. Posey et al. IMMUNITY
- Roles of regulatory T cells in cancer immunity
- (2016) Yoshiko Takeuchi et al. INTERNATIONAL IMMUNOLOGY
- CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignancies
- (2016) Annette Romanski et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Preparation of Cytokine-activated NK Cells for Use in Adoptive Cell Therapy in Cancer Patients
- (2016) Monique M. van Ostaijen-ten Dam et al. JOURNAL OF IMMUNOTHERAPY
- Targeting natural killer cells in cancer immunotherapy
- (2016) Camille Guillerey et al. NATURE IMMUNOLOGY
- Helper and cytotoxic T-cell subsets (Th1, Th2, Tc1, and Tc2) in benign and malignant salivary gland tumors
- (2016) MR Haghshenas et al. ORAL DISEASES
- Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ Tumors
- (2016) Radhika Thokala et al. PLoS One
- PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma
- (2016) Asma Beldi-Ferchiou et al. Oncotarget
- The concept of immune surveillance against tumors: The first theories
- (2016) Domenico Ribatti Oncotarget
- Phase I Study of Random Healthy Donor-Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors
- (2016) Y. Yang et al. Cancer Immunology Research
- A New Biological Feature of Natural Killer Cells: The Recognition of Solid Tumor-Derived Cancer Stem Cells
- (2016) Rossana Tallerico et al. Frontiers in Immunology
- Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G
- (2016) Sareetha Kailayangiri et al. OncoImmunology
- CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
- (2015) S. L. Maude et al. BLOOD
- Immunosuppression associated with chronic inflammation in the tumor microenvironment
- (2015) Dingzhi Wang et al. CARCINOGENESIS
- Challenges of cancer therapy with natural killer cells
- (2015) Hans Klingemann CYTOTHERAPY
- A phase I/II trial of interleukin-15–stimulated natural killer cell infusion after haplo-identical stem cell transplantation for pediatric refractory solid tumors
- (2015) Antonio Pérez-Martínez et al. CYTOTHERAPY
- DAP12-Based Activating Chimeric Antigen Receptor for NK Cell Tumor Immunotherapy
- (2015) Katrin Töpfer et al. JOURNAL OF IMMUNOLOGY
- Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma
- (2015) Nadja Müller et al. JOURNAL OF IMMUNOTHERAPY
- Natural killer (NK) cells and anti-tumor therapeutic mAb: unexplored interactions
- (2015) Simone Battella et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor
- (2015) Kurt Schönfeld et al. MOLECULAR THERAPY
- Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer
- (2015) David L. Hermanson et al. STEM CELLS
- T-cell exhaustion in the tumor microenvironment
- (2015) Y Jiang et al. Cell Death & Disease
- Advantages and applications of CAR-expressing natural killer cells
- (2015) Wolfgang Glienke et al. Frontiers in Pharmacology
- Utilizing Chimeric Antigen Receptors to Direct Natural Killer Cell Activity
- (2015) David L. Hermanson et al. Frontiers in Immunology
- Genetic Manipulation of NK Cells for Cancer Immunotherapy: Techniques and Clinical Implications
- (2015) Mattias Carlsten et al. Frontiers in Immunology
- Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells
- (2015) Annie A Wu et al. OncoImmunology
- Adaptive immune responses mediated by natural killer cells
- (2015) Silke Paust et al. IMMUNOLOGICAL REVIEWS
- CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells
- (2015) Jianfeng Han et al. Scientific Reports
- Cutting Edge: Priming of NK Cells by IL-18
- (2014) J. Chaix et al. JOURNAL OF IMMUNOLOGY
- Gene Therapy for Wiskott-Aldrich Syndrome--Long-Term Efficacy and Genotoxicity
- (2014) C. J. Braun et al. Science Translational Medicine
- Primary extramedullary spinal melanoma mimicking spinal meningioma: A case report and literature review
- (2014) YU-PING LI et al. Oncology Letters
- Improving the Outcome of Leukemia by Natural Killer Cell-Based Immunotherapeutic Strategies
- (2014) Salem Chouaib et al. Frontiers in Immunology
- Are natural killer cells superior CAR drivers?
- (2014) Hans Klingemann OncoImmunology
- Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
- (2013) Eric O. Long et al. Annual Review of Immunology
- Identification of a cellular ligand for the natural cytotoxicity receptor NKp44
- (2013) F. Baychelier et al. BLOOD
- A Chimeric Receptor with NKG2D Specificity Enhances Natural Killer Cell Activation and Killing of Tumor Cells
- (2013) Y.-H. Chang et al. CANCER RESEARCH
- Molecular mechanisms of natural killer cell activation in response to cellular stress
- (2013) C J Chan et al. CELL DEATH AND DIFFERENTIATION
- NK cell-based immunotherapy for malignant diseases
- (2013) Min Cheng et al. Cellular & Molecular Immunology
- MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells
- (2013) P. Leone et al. JNCI-Journal of the National Cancer Institute
- Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer
- (2013) Yun-Peng Peng et al. Journal of Translational Medicine
- CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma
- (2013) J Chu et al. LEUKEMIA
- Transfection of chimeric anti-CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells
- (2013) Hua Jiang et al. Molecular Oncology
- Antigen Presenting Cell-Mediated Expansion of Human Umbilical Cord Blood Yields Log-Scale Expansion of Natural Killer Cells with Anti-Myeloma Activity
- (2013) Nina Shah et al. PLoS One
- Memory of Infections: An Emerging Role for Natural Killer Cells
- (2013) Alexander Rölle et al. PLoS Pathogens
- PD-1 Expression on Peripheral Blood Cells Increases with Stage in Renal Cell Carcinoma Patients and Is Rapidly Reduced after Surgical Tumor Resection
- (2013) A. W. MacFarlane et al. Cancer Immunology Research
- Expression of IL-15 in NK cells results in rapid enrichment and selective cytotoxicity of gene-modified effectors that carry a tumor-specific antigen receptor
- (2012) Christiane Sahm et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cancer immunoediting by the innate immune system in the absence of adaptive immunity
- (2012) Timothy O’Sullivan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Immune Surveillance Properties of Human NK Cell-Derived Exosomes
- (2012) L. Lugini et al. JOURNAL OF IMMUNOLOGY
- Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques
- (2011) T. A. Waldmann et al. BLOOD
- Retargeting NK92 cells using an HLA-A2-restricted, EBNA3C-specific chimeric antigen receptor
- (2011) D V Tassev et al. CANCER GENE THERAPY
- Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO
- (2011) Tuanjie Li et al. CANCER LETTERS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The 'T-cell-ness' of NK cells: unexpected similarities between NK cells and T cells
- (2011) E. Narni-Mancinelli et al. INTERNATIONAL IMMUNOLOGY
- Molecular Basis for LLT1 Protein Recognition by Human CD161 Protein (NKRP1A/KLRB1)
- (2011) Jun Kamishikiryo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
- (2011) Emilie Mamessier et al. JOURNAL OF CLINICAL INVESTIGATION
- Proliferating Cell Nuclear Antigen Is a Novel Inhibitory Ligand for the Natural Cytotoxicity Receptor NKp44
- (2011) B. Rosental et al. JOURNAL OF IMMUNOLOGY
- Modulation of Natural Killer Cell Anti-Tumor Reactivity by Platelets
- (2011) Theresa Placke et al. Journal of Innate Immunity
- Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
- (2011) Jan Spanholtz et al. PLoS One
- Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection
- (2011) S. Lopez-Verges et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity
- (2011) Chuanfeng Wu et al. Frontiers of Medicine
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
- (2010) Richard A Morgan et al. MOLECULAR THERAPY
- Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease
- (2010) Stefan Stein et al. NATURE MEDICINE
- Revisiting human natural killer cell subset function revealed cytolytic CD56dimCD16+ NK cells as rapid producers of abundant IFN- on activation
- (2010) A. De Maria et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity
- (2009) P. S. Woll et al. BLOOD
- NK cell-mediated killing of target cells triggers robust antigen-specific T cell-mediated and humoral responses
- (2009) P. Krebs et al. BLOOD
- Macrophage- and Dendritic-Cell-Derived Interleukin-15 Receptor Alpha Supports Homeostasis of Distinct CD8+ T Cell Subsets
- (2009) Erwan Mortier et al. IMMUNITY
- NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo
- (2009) Tadepally Lakshmikanth et al. JOURNAL OF CLINICAL INVESTIGATION
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
- (2009) Cameron S. Brandt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells
- (2009) M. Carlsten et al. JOURNAL OF IMMUNOLOGY
- Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity
- (2009) M. Balsamo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A role for interleukin-12/23 in the maturation of human natural killer and CD56+ T cells in vivo
- (2008) S. Guia et al. BLOOD
- Human natural killer cells
- (2008) M. A. Caligiuri BLOOD
- Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
- (2008) Salima Hacein-Bey-Abina et al. JOURNAL OF CLINICAL INVESTIGATION
- Ligand-Based Targeting of Apoptosis in Cancer: The Potential of Recombinant Human Apoptosis Ligand 2/Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (rhApo2L/TRAIL)
- (2008) Avi Ashkenazi et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started